hotspot -WSS

hotspot

author：hotspot 2025-08-11 07:58:48 - browse：4217

AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July. Gonzalez had previously said he would depart when AbbVie had a plan in place to move on from its best-selling drug, Humira, which is now facing competition from cheaper biosimilars.

He will be replaced by Chief Operating Officer Robert Michael, who, like Gonzalez, is a longtime AbbVie executive. Gonzalez, 70, will become executive chairman of the board of directors.

Gonzalez should be a sobering reminder to the drug industry’s critics of how resilient a CEO’s reputation can be. Because while he has been a subject of nearly constant criticism for AbbVie’s handling of Humira and the patents protecting it, investors are likely to remember him fondly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： The U.S. needs a new definition of substance use “recovery”

WSS

Swim instructor mom warns parents not to buy blue swimsuits for kids

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Medicare wants to send $9 billion to 340B hospitals

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Biogen joins immunology wave with $1.15 billion acquisition of HI

Recent heat wave in the Mediterranean caused by climate change: Study

hotspot

hotspot

leisure time

Tori Bowie and the unacceptable rates of Black maternal death

Investigation reveals sickle cell patients pressured into sterilizations

Alkermes shareholders re

Biden’s NIH nominee is languishing in Congress

Tori Bowie and the unacceptable rates of Black maternal death

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

The cancer drug shortage isn’t new — and neither are the solutions

Digital health: a case of mistaken identity

Moonlake's readout produced a cash windfall. Risks remain

Pandemic and All Hazards Preparedness Act needs lean update

explore

White House announces new plan to address the growing threat of xylazine in overdose crisis

Fentanyl is making it harder to start addiction treatment

As a primary care physician, here's how I hope to partner with AI

Making the case for fair compensation in clinical trials

Recent heat wave in the Mediterranean caused by climate change: Study

Giraffe named Twiga, who was among the oldest cared for by humans, died at age 31 at East Texas zoo

leisure time

focus

hotspot

explore